Abstract 2910: Targeting thioredoxin reductase 1 (TrxR1) suppresses TAZ-driven glioblastoma progression
Miaolu Tang(Penn State Milton S. Hershey Medical Center), Wei Li(Penn State Milton S. Hershey Medical Center), Jessica E. Thorpe(Penn State Milton S. Hershey Medical Center), Kaitlyn Dirks(Penn State Milton S. Hershey Medical Center), Soo Yeon Kim(Seoul National University Hospital)
Cited by 0
Related Papers
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression
|Nature Communications|2020|409
Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program
|Advanced Science|2021|56
YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
|Journal of Experimental & Clinical Cancer Research|2017|49
Inhibition of thioredoxin reductase 1 sensitizes glucose-starved glioblastoma cells to disulfidptosis
|Cell Death and Differentiation|2024|35
Regulatory Mechanisms of lncRNAs and Their Target Gene Signaling Pathways in Laryngeal Squamous Cell Carcinoma
|Frontiers in Pharmacology|2020|25